Get the Stockscreener App
7.31
0.27%
0.02
Ocular Therapeutix Inc Stock (OCUL) Forecast
The Ocular Therapeutix Inc (OCUL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $7.4351, representing a +1.71% increase from the current price of $7.31. The highest analyst price target is $8.18, and the lowest is $6.6901.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month OCUL Price Target
Average 5.7058
(-21.94% Downside)
Is Ocular Therapeutix Inc (OCUL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 46.57 | Neutral |
| STOCH(9,6) | 54.21 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.5227 | Buy |
| ADX(14) | 41.18 | Sell |
| William %R | -25.14 | Neutral |
| CCI(14) | 69.18 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.719
Buy
|
6.943
Buy
|
| MA20 |
7.02
Buy
|
7.2604
Buy
|
| MA50 |
8.8945
Sell
|
8.2043
Sell
|
| MA100 |
9.1522
Sell
|
8.7941
Sell
|
| MA200 |
9.138
Sell
|
9.4608
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, OCUL could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 8 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on OCUL, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 46.57 indicates that OCUL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 54.21 indicates that OCUL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that OCUL is oversold. This suggests that OCUL price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 41.18 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 69.18 indicates that OCUL is still overbought but not to an extreme extent.
Long-term OCUL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Ocular Therapeutix Inc financial reports and earnings history, Ocular Therapeutix Inc (OCUL) stock could reach $9.7183 by 2030, $6.3046 by 2040 and $5.7775 by 2050. See the projected annual prices until 2050 of the Ocular Therapeutix Inc stock below:
- Ocular Therapeutix Inc (OCUL) is expected to reach an average price of $6.3334 in 2035, with a high prediction of $6.5034 and a low estimate of $4.4129. This indicates an $-13.36% rise from the last recorded price of $7.31.
- Ocular Therapeutix Inc (OCUL) stock is projected to chart a bullish course in 2040, with an average price target of $5.5551, representing an $-24.01% surge from its current level. The forecast ranges from a conservative $5.3751 to a sky-high $6.3046.
- Our analysts predict Ocular Therapeutix Inc (OCUL) to jump -44.96% by 2045, soaring from $3.8633 to an average price of $4.0233, potentially reaching $4.4529. While $3.8633 is the low estimate, the potential upside is significant.
- Ocular Therapeutix Inc (OCUL) stock is expected to climb by 2050, reaching an average of $4.7982, a $-34.36% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.7775 and $4.5182, respectively, highlighting the market's uncertainty.
Ocular Therapeutix Inc Stock (OCUL) Year by Year Forecast
Ocular Therapeutix Inc Stock (OCUL) Price Forecast for 2026
The predicted value for Ocular Therapeutix Inc (OCUL) in 2026 is set at an average of $9.515. Estimates vary from a peak of $13.03 to a trough of $6.00, indicating an +30.16% surge from the present price of $7.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $7.1602 | $6.6901 | $8.18 | -2.05% |
| December, 2026 | $7.5404 | $6.3403 | $7.7103 | +3.15% |
Ocular Therapeutix Inc Stock (OCUL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Ocular Therapeutix Inc (OCUL) is $5.4661, with a high forecast of $7.7005 and a low forecast of $3.2316. This indicates an -25.22% decrease from the last price of $7.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.8206 | $5.7706 | $7.7005 | -20.37% |
| February, 2027 | $5.7808 | $5.4406 | $6.1908 | -20.92% |
| March, 2027 | $5.631 | $5.0309 | $6.091 | -22.97% |
| April, 2027 | $5.1712 | $5.1512 | $5.8511 | -29.26% |
| May, 2027 | $3.7915 | $3.7915 | $5.7613 | -48.13% |
| June, 2027 | $3.4517 | $3.2316 | $4.1366 | -52.78% |
| July, 2027 | $4.3119 | $3.2817 | $4.7319 | -41.01% |
| August, 2027 | $4.6921 | $3.9927 | $4.9921 | -35.81% |
| September, 2027 | $5.5523 | $4.4722 | $6.1423 | -24.04% |
| October, 2027 | $6.3025 | $5.2724 | $6.5025 | -13.78% |
| November, 2027 | $4.4428 | $4.1028 | $6.8476 | -39.22% |
| December, 2027 | $3.823 | $3.6436 | $4.7328 | -47.70% |
Ocular Therapeutix Inc Stock (OCUL) Price Forecast for 2028
In 2028, Ocular Therapeutix Inc (OCUL) is projected to reach an average price of $5.5891, with a high projection of $8.2848 and a low estimate of $2.8933. This indicates an -23.54% fall from the last price of $7.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.4532 | $3.093 | $3.938 | -52.76% |
| February, 2028 | $3.1334 | $2.8933 | $3.4733 | -57.13% |
| March, 2028 | $4.2036 | $3.0935 | $4.5436 | -42.49% |
| April, 2028 | $6.5938 | $4.1037 | $6.8138 | -9.80% |
| May, 2028 | $5.2841 | $5.0756 | $6.7339 | -27.71% |
| June, 2028 | $5.5843 | $5.1225 | $5.8043 | -23.61% |
| July, 2028 | $6.7845 | $5.6243 | $7.1895 | -7.19% |
| August, 2028 | $7.7547 | $6.4096 | $8.0647 | +6.08% |
| September, 2028 | $5.2149 | $4.7748 | $8.2848 | -28.66% |
| October, 2028 | $4.8352 | $4.5452 | $5.435 | -33.86% |
| November, 2028 | $4.1054 | $3.9852 | $4.8853 | -43.84% |
| December, 2028 | $3.5156 | $3.4856 | $4.4855 | -51.91% |
Ocular Therapeutix Inc Stock (OCUL) Price Forecast for 2029
The 2029 price forecast for Ocular Therapeutix Inc Stock (OCUL) is $6.979 on average, with a high prediction of $11.64 and a low estimate of $2.321. This represents an -4.53% decrease from the previous price of $7.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.7458 | $2.5558 | $3.7156 | -62.44% |
| February, 2029 | $2.606 | $2.321 | $3.7859 | -64.35% |
| March, 2029 | $3.9462 | $2.4711 | $4.2962 | -46.02% |
| April, 2029 | $4.7115 | $3.5713 | $5.2014 | -35.55% |
| May, 2029 | $5.5067 | $4.0864 | $5.7267 | -24.67% |
| June, 2029 | $10.39 | $5.0467 | $10.88 | +42.09% |
| July, 2029 | $9.4271 | $9.157 | $11.64 | +28.96% |
| August, 2029 | $5.0723 | $4.3873 | $9.4284 | -30.61% |
| September, 2029 | $6.4975 | $4.9475 | $6.9274 | -11.11% |
| October, 2029 | $6.5778 | $5.1177 | $6.7728 | -10.02% |
| November, 2029 | $8.178 | $6.5578 | $9.008 | +11.87% |
| December, 2029 | $8.4382 | $7.2682 | $9.2982 | +15.43% |
Ocular Therapeutix Inc Stock (OCUL) Price Forecast for 2030
Ocular Therapeutix Inc Stock (OCUL) is expected to reach an average price of $9.117 in 2030, with a high forecast of $12.10 and a low forecast of $6.1301. This signifies an +24.72% surge from the last price of $7.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $9.3284 | $8.4383 | $9.7183 | +27.61% |
| February, 2030 | $10.17 | $8.7685 | $10.33 | +39.11% |
| March, 2030 | $10.86 | $9.2587 | $12.10 | +48.55% |
| April, 2030 | $10.22 | $8.539 | $11.58 | +39.80% |
| May, 2030 | $8.7693 | $8.4792 | $10.54 | +19.96% |
| June, 2030 | $8.3395 | $8.0245 | $9.5494 | +14.08% |
| July, 2030 | $7.3297 | $7.3197 | $8.6396 | +0.27% |
| August, 2030 | $7.8399 | $6.1948 | $9.2499 | +7.25% |
| September, 2030 | $7.6402 | $6.1301 | $8.37 | +4.52% |
| October, 2030 | $7.3904 | $7.1704 | $9.2253 | +1.10% |
| November, 2030 | $9.3506 | $7.0204 | $9.3706 | +27.91% |
| December, 2030 | $9.9508 | $8.3607 | $10.33 | +36.13% |
4.11%
2.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):